Cigna Group (CI) vs Labcorp (LH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Labcorp (LH) has outperformed Cigna Group (CI) over the past year, gaining 11.6% versus a loss of 9.3%. Over five years, CI leads with a +35.1% price change compared with +34.0% for LH. Cigna Group is the larger company by market cap ($73.59 billion vs $25.30 billion), about 2.9 times the size.
On valuation, Cigna Group trades at a lower forward P/E (8.3x vs 15.7x for Labcorp). Cigna Group offers the higher dividend yield (2.20% vs 0.92%). Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus 2.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CI | LH |
|---|---|---|
| Share price | $278.51 | $311.97 |
| Market cap | $73.59B | $25.30B |
| 1-day change | +1.51% | +0.08% |
| YTD return | +1.19% | +24.35% |
| 1-year return | -9.32% | +11.57% |
| 5-year return | +35.07% | +34.02% |
| P/E ratio (TTM) | 11.51 | 25.80 |
| Forward P/E | 8.31 | 15.73 |
| EPS (TTM) | $24.19 | $12.09 |
| Dividend yield | 2.20% | 0.92% |
| Annual dividend | $6.14 | $2.88 |
| Revenue (latest FY) | $274.90B | $13.95B |
| Revenue growth (YoY) | +11.24% | +7.25% |
| Net income (latest FY) | $5.96B | $876.50M |
| Gross margin | 21.79% | 28.76% |
| Operating margin | 3.35% | 9.92% |
| Net margin | 2.17% | 6.28% |
| 52-week high | $312.18 | $341.80 |
| 52-week low | $239.51 | $244.52 |
| Distance from 52-week high | -10.79% | -8.73% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +22.90% | +10.33% |
| Average volume | 1.67M | 740.44K |
| Shares outstanding | 264.24M | 81.10M |
| Employees | 65,669 | 71,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cigna Group is about 2.9 times larger than Labcorp by market value ($73.59B vs $25.30B).
- LH has outperformed CI by 20.9 percentage points over the past year.
- Labcorp trades at a higher earnings multiple (25.8x vs 11.5x trailing P/E).
- Cigna Group offers a meaningfully higher dividend yield (2.20% vs 0.92%).
About Cigna Group
CI stock →The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Health Care · Medical Specialities · 65,669 employees
About Labcorp
LH stock →Labcorp Holdings Inc. provides laboratory services.
Health Care · Medical Specialities · 71,000 employees
CI vs LH FAQ
Which is bigger, Cigna Group or Labcorp?
Cigna Group (CI) is larger, with a market capitalization of $73.59B compared with $25.30B for Labcorp (LH).
Which stock has performed better over the past year, CI or LH?
LH returned +11.57% over the past 12 months, compared with -9.32% for CI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CI or LH?
CI has the lower trailing P/E at 11.5, versus 25.8 for LH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cigna Group or Labcorp?
Cigna Group has the higher yield at 2.20%, compared with 0.92% for Labcorp.
Are Cigna Group and Labcorp in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.